Myovant Sciences Ltd. Annual Operating Income (Loss) in USD from 2016 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Myovant Sciences Ltd. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2021.
  • Myovant Sciences Ltd. Operating Income (Loss) for the quarter ending December 31, 2022 was -$51.9M, a 13.1% increase year-over-year.
  • Myovant Sciences Ltd. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$147M, a 30.8% increase year-over-year.
  • Myovant Sciences Ltd. annual Operating Income (Loss) for 2021 was -$187M, a 28.2% increase from 2020.
  • Myovant Sciences Ltd. annual Operating Income (Loss) for 2020 was -$261M, a 5.13% increase from 2019.
  • Myovant Sciences Ltd. annual Operating Income (Loss) for 2019 was -$275M, a 3.8% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$187M +$73.4M +28.2% Apr 1, 2021 Mar 31, 2022 10-K 2022-05-11
2020 -$261M +$14.1M +5.13% Apr 1, 2020 Mar 31, 2021 10-K 2022-05-11
2019 -$275M -$10.1M -3.8% Apr 1, 2019 Mar 31, 2020 10-K 2022-05-11
2018 -$265M -$122M -85.1% Apr 1, 2018 Mar 31, 2019 10-K 2021-05-11
2017 -$143M -$59.5M -71.3% Apr 1, 2017 Mar 31, 2018 10-K 2019-05-24
2016 -$83.5M Apr 1, 2016 Mar 31, 2017 10-K 2019-05-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.